Posts Tagged chemotherapy

Why some doctors have a problem with Complementary Medicine

Originally published in January 2003 icon

Pride & Prejudice

Dr. Graham Henderson

Why some doctors have a problem with Complementary Medicine (and the patients who ask about it).

Graham Henderson is a public health doctor working for the NHS in Surrey. He trained at the Royal London Hospital and worked in children’s and adult medicine, and in general practice in Australia, before specialising in public health. He has been a consultant for ten years and is a former medical director of an NHS trust hospital.

By Dr. Graham Henderson

Medical Report

Taking the kids to school this morning came the inevitable comments from the back seat; “Dad, you’re going too fast; Dad, you forgot to signal at that junction”.

How many of us love back-seat driving, even when we love the people who’re doing it more than life itself? It’s even worse, especially if you’re having a bad day, if the back-seat driver is right, and you know that you did in fact make a tiny little error of judgement on that last roundabout!

Open quotesIt’s in all the training – give the patient
confidenceClose quotes

When we’re ill we feel insecure, dis-empowered, unable to assert ourselves. We see our advisors, our doctors, as wise, all-knowing, confidence-inspiring. At least, that’s how we want them to be. They know that. It’s in all the training – “give the patient confidence”. But the doctor also knows that he’s human; he’s not all-knowing; sometimes he makes mistakes; sometimes he can’t deal with the emotional stress of the consultation.

So what happens to the doctor when:

»

He (or she) hears you asking about vitamins, dietary approaches to cancer, or reflexology?

»

You arrive with a sheaf of printouts from the internet?

»

You want to know his views on a book by a cancer sufferer that he’s never read?

He gets scared, that’s what.

Because suddenly, he can’t do his job. The doctor’s professional respect, self-esteem, position in the community, everything, is tied up in his/her ability to give you the information, reassurance, treatement you need, or to send you to a man who does. You don’t say that someone “works” as a doctor; you say he or she “is” a doctor. So if he’s not a good enough doctor, he might feel he’s not good enough at anything at all! And most doctors don’t know much about dealing with illness other than with conventional (allopathic) medicine.

Open quotesYou don’t say that someone ‘works’ as a doctor; you say he or she ‘is’ a doctorClose quotes

Clearly, it’s not the same for all doctors. They come in different shapes and sizes, like everyone else. But there is a pattern, conditioned by medical training, of feeling threatened by the knowledgable, questioning patient.

Modern medical training has spotted it, and younger doctors have been shown ways of dealing with it. But we’ve all heard too many stories of patients who “couldn’t get the doctor to listen”, felt brushed off, or even, in the worst cases got laughed at, to believe that it isn’t a problem.

So, to go back to the surgery. We’ve got one sick person (you) who’s frightended because you’re ill. And on the other side we’ve got another person, the doctor, who’s frightened as well, because your efforts to help yourself, to get some control over your illness and what’s happening to you, have accidentally threatened the doctor’s very sense of self-worth.

Now we have to careful here. You, the patient, are frightened because you’re ill. Horrible things are happening to you. You’re in the middle of a disaster. You’re entitled to be scared. The doctor, on the other hand, is a professional who ought to be able to deal with this.

Open quotesWhat both doctor and patient need is to get into a constructive
conversationClose quotes

His difficulty dealing with it is professional weakness; letting that develop into irritation or anger is professionally unethical. So let there be no confusion about who’s right and who’s wrong. The point of this article is not to dish out blame. What both doctor and patient need is to get into a constructive conversation.

In my experience there’s three groups of doctors when it comes to complementary medicine – apart from the rare enthusiasts who actually know something about it. If you can spot which one you’ve got, then you can try and make the relationship work for you.

1:

The first, and easiest to deal with, are the ones who accept that they ought to know about complementary therapies, but have never quite got round to finding out. These are the best ones to deal with, because you can challenge them to find out about it; perhaps even work with them to explore the subject together. You might want to offer them some info (gently!), but you should probably let them go off and do some research on their own before coming back to the discussion later. That way you can have a proper conversation; otherwise it’s just you giving them a lecture. Ideally, the conversation ends with “I’ve always wanted to find out about this, but never got round to it. Now you’ve given me a reason. Come and see me later in the week and we’ll go into it together”.

2:

The second group are the doctors who really don’t think it’s anything to do with them, and are fundamentally unpersuadable. They’ve either looked into it and decided its a load of old codswallop (of which more below) or, even worse, have not really thought about it but have decided the same thing anyway! Quite frankly, there’s not a lot of point pushing your ideas in this situation. You probably know more about it than the doctor, you’re very unlikely to bring them round to your point of view, and you’ll just be wasting your time. Take what they’re offering in the way of allopathic medicine and look for complementary help elsewhere. Or, if you need your doctor to understand complementary medicine, change your doctor.

3:

Finally, and perhaps the hardest to decide about, are the doctors who know very little about complementary medicine but could be persuaded if you (and they) had enough time. Here is your opportunity to lead them into the subject gently. Not intimidating them and making them feel stupid with your superior knowledge, but leading them gently to the point where they actually want to spend the next few evenings reading the book you’ve suggested, researching the internet, or going to the library.

When I worked in a factory before becoming a doctor, the woman in the packing department gave me a piece of advice I’ve never forgotten. “If you want someone to do something for you” she said, “make sure they think it was their idea in the first place”. I’ve since found out that you can earn a fortune as a “change management consultant” for telling people things like that. It was good advice then, and it’s where you’re trying to get to with your doctor. You want to leave him with the sense that he’s missing something really useful and interesting. Something that he really can’t afford not to know about.

Open quotesIf you want someone to do something for you, make sure they think it was their idea in the first
placeClose quotes

The other thing I ought to mention, in a piece that’s trying to tell you how to understand your doctor, is why conscientious, caring doctors sometimes reject the complementary approach. Doctors today are trained in the scientific approach, although the best doctors combine this with the “art” of medicine, which accepts that science can’t explain everything about people. The scientific side of medicine asks that everything, all medicines, all operations, all treatments, be subjected to rigorous testing and “proof”. So when a new drug is invented, or a new operation suggested, it has to be put to the test. Compared with the existing treatment, under controlled conditions, preferably in a “blind” trial where neither the doctor nor the patient knows whether they’re taking the old or the new treatment.

This means that all bias is put aside, and only rigorous objective measurements show whether the new treatment is as good as, better, or worse than the old. And as patients, we want nothing less. We want to know that we’re being offered the best treatment, not just the latest fad from a “modern” doctor, or the stuff they’ve always used from a traditionalist.

But a lot of complementary treatments haven’t been tested through this sort of process. Partly, this is because the process takes a long time, and is expensive, so it can only be done if you can get the money back from drug sales when the tests are complete. Or because many complementary approaches tailor treatments precisely for individual patients, making it very hard to test a “standard” treatment.

But perhaps most often complementary approaches are hard to test objectively because they rely heavily on drawing out the patient’s inner resources to fight the illness. This is often in combination with a very strong relationship between therapist and patient, and these factors are just not amenable to standardisation and reproduction so they can easily be measured.

Open quotesRemember, in the end, it’s your lifeClose quotes

So, sometimes, even the very best and most caring doctors find themselves unable to accept that complementary approaches may be the right thing for you; they may honestly believe that, in recommending you explore alternatives to their allopathic approach, they may be doing you harm. I know this article appears to ask a lot of you, the patient. It asks you to try and understand your doctor when he doesn’t understand you. It asks you to consider his vulnerability at a time when he really ought to be considering yours. But the ICON approach is about helping YOU to take control of YOUR illness.

Use your doctors for what they can give you. Help them to a greater understanding if you can. Listen to their advice, and understand their perspective. But remember, in the end, it’s your life.

The final decisions are your yours to make.


Tags: , , , , ,

Cancer – Chemotherapy and Anti-Oxidants

Originally published in icon Issue 4 2006

Anto -o

Increasingly, the orthodox medical world is demanding that all cancer therapies must have scientifically based research evidence to support their use. The ‘gold standard’, often quoted, is largely limited to chemotherapy drugs and is called the ‘Clinical Trial’.

At icon we agree with this need.  Unfortunately, less clear is which types of research are acceptable.  Scientists attempt to produce hard evidence on the successful performance of a drug, citing how many people in a trial group had a positive effect against an identical group taking (unknowingly) a placebo.  Various other controls are incorporated to rule out unwanted outside influences.

Open quotes accurate measurements of the negative side effects of a drug are every bit as important as measuring the benefits Close quotes

However the rigour of exactly how many people benefit from the drug often falls woefully short when the issue of side effects is considered. These are most usually ‘touched upon’ rather than provided as accurate percentages in the same way the benefits are measured. We have covered (in a previous issue – Vol 2 ; 2006) the concerns expressed by experts in the Lancet Oncology magazine of the negative effects of, say, monoclonal antibodies. As we have expressed before inicon, accurate measurements over a sensible period of time of the negative side effects of a drug are every bit as important as measuring the benefits. Furthermore, in some cases, euphoria on the positive findings is seeing some drugs pulled out of Clinical Trials before they have even completed their allotted time span.

anti-o2The other problem with the use of ‘hard scientific evidence’ is that, all too often, papers are presented by ‘interested parties’ with a resultant bias. Again, in 2004 and 2005 two ‘megastudies’ of anti-oxidants were covered in this magazine. In response to a concern expressed by Professor Tony Howell, one of our charity patrons, we analysed the data to find, for example in one case with vitamin E, that far from being a ‘megastudy’, the scientists had only looked at 14 studies, (far less than we considered for our own report on vitamin E) and far from looking at the naturalvitamin in its 4 tocopherol forms or its 4 tocotrienol forms, the only research taken by the scientists was for the synthetic vitamin E in solely the alpha-tocopherol form. (Which, for example, has virtually no proven benefit with breast cancer, unlike the tocotrienol forms). From this they managed to conclude that ‘vitamin E could actually increase your risks of dying by 10-30%’. Poor research at best (Cancer Research UK agreed with us), but possibly by co-incidence, it was published shortly before the decisions in the EU were to be made on whether vitamins should be treated as drugs and which would be permitted for sale in the shops. In Cancer Watch we cover research, again from the Lancet, on how ‘vested interest’ research is reducing the credibility of Doctors and Specialists alike amongst the general public.

A further problem occurs in providing information on research and doctors.  In icon we previously reported on the senior Australian Government Medical Advisor who has set up a website for doctors on pharmaceutical clinical trials, listing all benefits and side effects, because he was so concerned that ‘doctors only get that information from PR releases and media coverage, both of which are provided by the pharmaceutical companies themselves and may be biased’.

Doctors don’t get time to read endless research reports and, anyway, outside the area of drug clinical trials lie a minefield of different types of research and, often subjective, opinion.

As an example, one of the most commonly asked questions by people ringing our offices is, ‘Should I be taking my anti-oxidants when I have chemo or radiotherapy?’

Our answer is a categoric, ‘YES’. Hitherto we have read the ‘tome’ by John Boik, one of the senior staff at the prestigious MD Anderson Cancer Centre in Houston, Texas. This book is over an inch thick, published in 2001 and called ‘Natural Compounds in cancer therapy’. It contains over 4000 references to scientific papers and basically concludes that, far from in some way interfering with the biochemical process involved in chemo or radiotherapy, taking anti-oxidants actually improves the success rates of both. Support for this stance came in 2005 – again covered in icon Cancer Watch, when UCLA produced the conclusion that healthy cells are self regulators and will pick up the maximum concentrations of anti-oxidants available in order to maximize their biochemical processes. However cancer cells have lost most of this regulatory ability and will overload on anti-oxidants. Their view is that this will help the chemo or radio ‘kill them off’.

Open quotes a number of oncologists adamantly tell their patients that they do not want them taking anti-oxidants during their chemo or radiotherapy …….but requests for ‘hard scientific research evidence’ supporting the oncologist’s concern have come to nothing Close quotes

The problem for us, and especially for the cancer patients who call us, is that a number of oncologists adamantly tell their patients that they do not want them taking anti-oxidants during their chemo or radiotherapy as this will somehow weaken the effect. Patients are thus ‘scared’ into dropping their supplementation programmes. Our problem is compounded because we are very open minded on this issue still, but frequent requests to be sent the ‘hard scientific research evidence’ supporting the oncologist’s concern have come to nothing. We would be happy to print it. But does any actually exist, or is the concern pure subjective opinion and mythology?

In September 2005 a paper was actually published in the USA in A Cancer Journal for Clinicians (Gabriella D’Andrea MD). More of an article than a genuine scientific paper, it warned against using anti-oxidants with chemo and radiotherapy. However by chance, or oversight, it missed all the papers supporting anti-oxidants, used only clinical laboratory research rather than human or epidemology

Open quotes specific and synthetic anti-oxidants areapproved by the FDA and recommended for use with chemotherapy Close quotes

studies, and omitted the fact that in certain cases (e.g. the use of amifostine) some specific and synthetic anti-oxidants are approved by the FDA and recommended for use with chemotherapy and are known to have enhancing benefits in, say, oral and lung cancers and child leukemia. icon, for example, carried clinical research in 2004 that vitamin E supplementation could produce the same positive effects from Tamoxifen, at a 25  per cent lowered drug dosage. Great for the patient – but not so great for the profitability of the pharmaceutical company concerned. We doubt any oncologist has even noticed the research.

anti-o3

The D’Andrea article did, however, re-open the debate about taking anti-oxidants with chemotherapy and radiotherapy.

The whole matter has recently been highlighted by Ralph W. Moss PhD, the famous US cancer researcher. In a paper ‘Should patients undergoing Chemotherapy and Radiotherapy be prescribed antioxidants? (Integrative Cancer Therapies Vol 5, 1; 63-82.http://ict.sagepub.com/cgi/reprint/5/1/63. Also on PubMed) Moss expertly takes the reader through the myriad of research, including clinical trials, stating clearly that the D’Andrea paper was incomplete and that there is far more information available than either she included or is widely acknowledged. His conclusion is that a ‘blanket rejection of the concurrent use of anti-oxidants with chemotherapy is not justified by the preponderance of evidence’. For the more scientifically biased amongst our readers we have listed below some of the main scientific references on this subject.

Open quotes If taking anti-oxidants is of such a concern, why do many of the same oncologists tell the patient to eat plenty of fresh fruit and vegetables instead? Close quotes

Moss raises another important point – one we have repeatedly made. If taking anti-oxidants is of such a concern, why do many of the same oncologists tell the patient to eat plenty of fresh fruit and vegetables instead? Is it because they believe fresh fruit and vegetables are devoid of anti-oxidants these days and thus can’t interfere with their chemotherapy? Or is it because they are fearful of the synthetically produced ones? (Just as we are – you’ll note in icon we continually tell you to take the natural forms). Perhaps it is neither of these. Perhaps they are just not aware of the enormous amount of research in the US alone.  However, the answer may lie in an article from the early days of icon, when Dr. Graham Henderson wrote a piece for us telling our readers just why UK Doctors were so negative towards complementary therapies. To summarise: UK Doctors want to be the fount of all knowledge for their patients, and many have neither studied formally, nor had the time to study since leaving medical school, these complementary therapies and especially nutrition. (Only recently a newly qualified doctor was in our offices openly stating that (apart from a morning on combating heart disease) she had not spent one day formally studying nutrition in her whole seven years training!) As Dr. Henderson concluded, most UK Doctors are outside their both knowledge and comfort zones.

Nothing brings this home more than reading Moss’ conclusions, one of which is that ‘Patients would be well advised to seek the opinion of physicians who are adequately trained and experienced in the intersection of 2 complex fields, that is, chemotherapy and nutritional oncology’.

If all UK NHS oncologists who qualify e-mail us on enquiries@canceractive.com with their name, phone number and qualifications we will happily publish a list in the magazine and on our web site. This debate will not be settled until we have more experts who are fully qualified in both oncology and nutritional therapy.

Meanwhile, a similar view on the benefits and the increasingly vacuous criticism of natural compounds as beneficial adjuncts to chemo and radiotherapy can be found in the article on Herbs by the expert Alan Hopking in icon Issue 3 2006.

For the record, we continue to recommend that all patients having chemo and radiotherapy supplement using natural supplements (like Chlorella, garlic, astragalus, Aloe Vera, medicinal mushrooms, natural vitamin E etc) as we increasingly find positive research-based evidence.  (For example:  Prasad K. N:  Int. Cancer Therapies 2004, 3:3, 310-323.  Multiple dietary antioxidant therapies enhance the efficacy of standard and experimental cancer therapies and decrease their toxicity. But we especially recommend that patients load up on the foods that can provide them with the biggest range of cancer fighting agents possible.

Open quotes Rainbow diet At Last – the definitive, research based book on how to build a diet to help beat cancer. Click here to read about it. Close quotes

References:

For those of you who want to check the scientific references used, we have selected a mere 75 from those recorded by Ralph Moss

************************************************************************

Some detailed references:

  • D’Andrea GM. Use of antioxidants during chemotherapy and radiotherapy should be avoided. CA Cancer J Clin. 2005;55:319-321
  • Parker-Pope T. Cancer and vitamins: patients urged to avoid supplements during treatment. Wall Street Journal. September 20, 2005:D1.
  • Cohen MH. Complementary and Alternative Medicine: Legal Boundaries and Regulatory Perspectives. Baltimore, Md: Johns Hopkins University Press; 1997.
  • Moss RW. Antioxidants Against Cancer. Brooklyn, NY: Equinox Press; 2000.
  • Prasad KN. Multiple dietary antioxidants enhance the efficacy of standard and experimental cancer therapies and decrease their toxicity. Integr Cancer Ther. 2004;3:310-322.
  • Conklin KA. Dietary antioxidants during cancer chemotherapy: impact on chemotherapeutic effectiveness and development of side effects. Nutr Cancer. 2000;37:1-18.
  • Conklin K. Chemotherapy-associated oxidative stress: impact on chemotherapeutic effectiveness. Integr Cancer Ther. 2004;3:294-300.
  • Jiang Q, Wong J, Fyrst H, Saba JD, Ames BN. Gammatocopherol or combinations of vitamin E forms induce cell death in human prostate cancer cells by interrupting sphingolipid synthesis. Proc Natl Acad Sci USA. 2004;101:17825-17830.
  • Ferrari CK. Functional foods, herbs and nutraceuticals: towards biochemical mechanisms of healthy aging. Biogerontology. 2004;5:275-289.
  • Drisko JA, Chapman J, Hunter VJ. The use of antioxidant therapies during chemotherapy. Gynecol Oncol. 2003;88:434-439.[CrossRef][Medline] [Order article via Infotrieve]
  • Chen Q, Espy MG, Krishna MC, et al. Pharmacologic ascorbic acid concentrations selectively kill cancer cells: action as a pro-drug to deliver hydrogen peroxide to tissues. Proc Natl Acad Sci U S A. 2005;102:13604-13609.[Abstract/Free Full Text]
  • Paiva SAR, Russell RM. Beta-carotene and other carotenoids as antioxidants. J Am Coll Nutr. 1999;18:426-433.[Abstract/Free Full Text]
  • Young AJ, Lowe GM. Antioxidant and prooxidant properties of carotenoids. Arch Biochem Biophys. 2001;385:20-27.[CrossRef][Medline] [Order article via Infotrieve]
  • Bairati I, Meyer F, Gelinas M, et al. Randomized trial of anti-oxidant vitamins to prevent acute adverse effects of radiation therapy in head and neck cancer patients. J Clin Oncol. 2005;23:5805-5813.[Abstract/Free Full Text]
  • Bairati I, Meyer F, Gelinas M, et al. A randomized trial of anti-oxidant vitamins to prevent second primary cancers in head and neck cancer patients. J Natl Cancer Inst. 2005;97:481-488.[Abstract/Free Full Text]
  • Camphausen K, Citrin D, Krishna MC, Mitchell JB. Implications for tumor control during protection of normal tissues with antioxidants. J Clin Oncol. 2005;23:5455-5457.[Free Full Text]
  • Block K. Antioxidants in the news. Integr Cancer Ther. 2005;4:271-273.[Free Full Text]
  • Creagan ET, Moertel CG, O’Fallon JR, et al. Failure of high-dose vitamin C (ascorbic acid) therapy to benefit patients with advanced cancer: a controlled trial. N Engl J Med. 1979;301:687-690.
  • Moertel CG, Fleming TR, Creagan ET, Rubin J, O’Connell MJ, Ames MM. High-dose vitamin C versus placebo in the treatment of patients with advanced cancer who have had no prior chemotherapy: a randomized double-blind comparison. N Engl J Med. 1985;312:137-141.
  • Padayatty SJ, Sun H, Wang Y, et al. Vitamin C pharmacokinetics: implications for oral and intravenous use. Ann Intern Med. 2004;140:533-537.[Abstract/Free Full Text]
  • Memorial Sloan-Kettering Cancer Center. Cancer tumors shown to consume large amounts of vitamin C [press release]. September 15, 2000. Available at: www.mskcc.com.
  • Newbold HL. Vitamin C Against Cancer. New York, NY: Stein & Day; 1979.
  • Gonzalez MJ, Miranda-Massari JR, Mora EM, et al. Orthomolecular oncology review: ascorbic acid and cancer 25 years later. Integr Cancer Ther. 2005;4:32-44.[Abstract/Free Full Text]
  • Jaakkola K, Lahteenmaki P, Laakso J, Harju E, Tykka H, Mahlberg K. Treatment with antioxidant and other nutrients in combination with chemotherapy and irradiation in patients with small-cell lung cancer. Anticancer Res. 1992;12:599-606.[Medline] [Order article via Infotrieve]
  • Lesperance ML, Olivotto IA, Forde N, et al. Mega-dose vitamins and minerals in the treatment of non-metastatic breast cancer: an historical cohort study. Breast Cancer Res Treat. 2002;76:137-143.[CrossRef][Medline] [Order article via Infotrieve]
  • Alam N, Shepherd FA, Winton T, et al. Compliance with postoperative adjuvant chemotherapy in non-small cell lung cancer: an analysis of National Cancer Institute of Canada and intergroup trial JBR.10 and a review of the literature. Lung Cancer. 2005;47:385-394.[CrossRef][Medline][Order article via Infotrieve]
  • Hoffer A. Comments on “Mega-Dose Vitamins and Minerals in the Treatment of Nonmetastatic Breast Cancer: An Historical Cohort Study.” Integr Cancer Ther. 2003;2:155-157.[Free Full Text]
  • Conklin K. Coenzyme q10 for prevention of anthracycline-induced cardiotoxicity. Integr Cancer Ther. 2005;4:110-130.[Abstract/Free Full Text]
  • Bertazzoli C, Sala L, Ballerini L, Watanabe T, Folkers K. Effect of adriamycin on the activity of the succinate dehydrogenasecoenzyme Q10 reductase of the rabbit myocardium. Res Commun Chem Pathol Pharmacol. 1976;15:797-800.[Medline] [Order article via Infotrieve]
  • Cortes EP, Gupta M, Chou C, Amin VC, Folkers K. Adriamycin cardiotoxicity: early detection by systolic time interval and possible prevention by coenzyme Q10. Cancer Treat Rep. 1978;62:887-891.[Medline] [Order article via Infotrieve]
  • Brash DE, Havre PA. New careers for antioxidants. Proc Natl Acad Sci U S A. 2002;99:13969-13971.[Free Full Text]
  • Shin DM, Khuri FR, Murphy B, et al. Combined interferon-alfa, 13-cis-retinoic acid, and alpha-tocopherol in locally advanced head and neck squamous cell carcinoma: novel bioadjuvant phase II trial. J Clin Oncol. 2001;19:3010-3017.[Abstract/Free Full Text]
  • Seixas-Silva JA Jr, Richards T, Khuri FR, et al. Phase 2 bioadjuvant study of interferon alfa-2a, isotretinoin, and vitamin E in locally advanced squamous cell carcinoma of the head and neck: long-term follow-up. Arch Otolaryngol Head Neck Surg. 2005;131:304-307.[Abstract/Free Full Text]
  • Pace A, Savarese A, Picardo M, et al. Neuroprotective effect of vitamin E supplementation in patients treated with cisplatin chemotherapy. J Clin Oncol. 2003;21:927-931.[Abstract/Free Full Text]
  • Argyriou AA, Chroni E, Koutras A, et al. Vitamin E for prophylaxis against chemotherapy-induced neuropathy: a randomized controlled trial. Neurology. 2005;64:26-31.[Abstract/Free Full Text]
  • Delanian S, Porcher R, Balla-Mekias S, Lefaix JL. Randomized, placebo-controlled trial of combined pentoxifylline and tocopherol for regression of superficial radiation-induced fibrosis. J Clin Oncol. 2003;21:2545-2550.[Abstract/Free Full Text]
  • Delanian S, Depondt J, Lefaix JL. Major healing of refractory mandible osteoradionecrosis after treatment combining pentoxifylline and tocopherol: a phase II trial. Head Neck. 2005;27:114-123.[CrossRef][Medline] [Order article via Infotrieve]
  • Pathak AK, Bhutani M, Guleria R, et al. Chemotherapy alone vs. chemotherapy plus high dose multiple antioxidants in patients with advanced non small cell lung cancer. J Am Coll Nutr. 2005;24:16-21.[Abstract/Free Full Text]
  • Kennedy M, Brunuinga K, Mutlu EA, Losurdo J, Choudhary S, Keshavarian A. Successful and sustained treatment of chronic radiation proctitis with antioxidant vitamins E and C. Am J Gastroenterol. 2001;96:1080-1084.[CrossRef][Medline] [Order article via Infotrieve]
  • Mahmoud F, Sarhill N, Mazurczak MA. The therapeutic application of melatonin in supportive care and palliative medicine. Am J Hosp Palliat Care. 2005;22:295-309.[Medline] [Order article via Infotrieve]
  • Jang MH, Jung SB, Lee MH, et al. Melatonin attenuates amyloid beta 25-35-induced apoptosis in mouse microglial BV2 cells. Neurosci Lett. 2005;380:26-31.[CrossRef][Medline] [Order article via Infotrieve]
  • Lissoni P, Chilelli M, Villa S, Cerizza L, Tancini G. Five years survival in metastatic non-small cell lung cancer patients treated with chemotherapy alone or chemotherapy and melatonin: a randomized trial. J Pineal Res. 2003;35:12-15.[CrossRef][Medline] [Order article via Infotrieve]
  • Cerea G, Vaghi M, Ardizzoia A, et al. Biomodulation of cancer chemotherapy for metastatic colorectal cancer: a randomized study of weekly low-dose irinotecan alone versus irinotecan plus the oncostatic pineal hormone melatonin in metastatic colorectal cancer patients progressing on 5-fluorouracil-containing combinations. Anticancer Res. 2003;23:1951-1954.[Medline] [Order article via Infotrieve]
  • Lissoni P, Malugani F, Bukovec R, et al. Reduction of cisplatin-induced anemia by the pineal indole 5-methoxytryptamine in metastatic lung cancer patients. Neuro Endocrinol Lett. 2003;24:83-85.[Medline] [Order article via Infotrieve]
  • Lissoni P, Bucovec R, Bonfanti A, et al. Thrombopoietic properties of 5-methoxytryptamine plus melatonin versus melatonin alone in the treatment of cancer-related thrombocytopenia. J Pineal Res. 2001;30:123-126.[CrossRef][Medline] [Order article via Infotrieve]
  • Rybak LP, Husain K, Morris C, Whitworth C, Somani S. Effect of protective agents against cisplatin ototoxicity. Am J Otol. 2000;21:513-520.[Medline] [Order article via Infotrieve]
  • Miyajima A, Nakashima J, Tachibana M, Nakamura K, Hayakawa M, Murai M. N-acetylcysteine modifies cisdichlorodiammineplatinum-induced effects in bladder cancer cells. Jpn J Cancer Res. 1999;90:565-570.[Medline] [Order article via Infotrieve]
  • Bohm S, Oriana S, Spatti G, et al. Dose intensification of platinum compounds with glutathione protection as induction chemotherapy for advanced ovarian carcinoma. Oncology. 1999;57:115-120.[CrossRef][Medline] [Order article via Infotrieve]
  • Smyth JF, Bowman A, Perren T, et al. Glutathione reduces the toxicity and improves quality of life of women diagnosed with ovarian cancer treated with cisplatin: results of a double-blind, randomised trial. Ann Oncol. 1997;8:569-573.[CrossRef][Medline] [Order article via Infotrieve]
  • Cascinu S, Catalano V, Cordella L, et al. Neuroprotective effect of reduced glutathione on oxaliplatin-based chemotherapy in advanced colorectal cancer: a randomized, double-blind, placebo-controlled trial. J Clin Oncol. 2002;20:3478-3483.[Abstract/Free Full Text]
  • National Cancer Institute. Overview of nutrition in cancer care. June 17, 2005. Available at:http://www.cancer.gov/cancerinfo/pdq/supportivecare/nutrition
  • Ladner C, Ehninger G, Gey KF, Clemens MR. Effect of etoposide (VP16-213) on lipid peroxidation and antioxidant status in a high-dose radiochemotherapy regimen. Cancer Chemother Pharmacol. 1989;25:210-212.[CrossRef][Medline] [Order article via Infotrieve]
  • Clemens MR, Ladner C, Ehninger G, et al. Plasma vitamin E and beta-carotene concentrations during radiochemotherapy preceding bone marrow transplantation. Am J Clin Nutr. 1990;51:216-219.[Abstract/Free Full Text]
  • Colasanto JM, Prasad P, Nash MA, Decker RH, Wilson LD. Nutritional support of patients undergoing radiation therapy for head and neck cancer. Oncology (Williston Park). 2005;19:371-379.[Medline] [Order article via Infotrieve]
  • Lissoni P, Paolorossi F, Ardizzoia A, et al. A randomized study of chemotherapy with cisplatin plus etoposide versus chemoendocrine therapy with cisplatin, etoposide and the pineal hormone melatonin as a first-line treatment of advanced non-small cell lung cancer patients in a poor clinical state. J Pineal Res. 1997;23:15-19.[Medline] [Order article via Infotrieve]
  • Yu D, Duan Y, Bao Y, Wei C, An L. Isoflavonoids from Astragalus mongholicus protect PC12 cells from toxicity induced by L-glutamate. J Ethnopharmacol. 2005;98:89-94.[CrossRef][Medline][Order article via Infotrieve]
  • Taixiang W, Munro AJ, Guanjian L. Chinese medical herbs for chemotherapy side effects in colorectal cancer patients. Cochrane Database Syst Rev. 2005:CD004540.
  • Kennedy DD, Ladas EJ, Rheingold SR, Blumberg J, Kelly KM. Antioxidant status decreases in children with acute lymphoblastic leukemia during the first six months of chemotherapy treatment. Pediatr Blood Cancer. 2005;44:378-385.[CrossRef][Medline] [Order article via Infotrieve]
  • Kennedy DD, Tucker KL, Ladas ED, Rheingold SR, Blumberg J, Kelly KM. Low antioxidant vitamin intakes are associated with increases in adverse effects of chemotherapy in children with acute lymphoblastic leukemia. Am J Clin Nutr. 2004;79:1029-1036.[Abstract/Free Full Text]
  • Yildirim I, Korkmaz A, Oter S, Ozcan A, Oztas E. Contribution of antioxidants to preventive effect of mesna in cyclophosphamide-induced hemorrhagic cystitis in rats. Cancer Chemother Pharmacol. 2004;54:469-473.[CrossRef][Medline] [Order article via Infotrieve]
  • Ozcan A, Korkmaz A, Oter S, Coskun O. Contribution of flavonoid antioxidants to the preventive effect of mesna in cyclophosphamide-induced cystitis in rats. Arch Toxicol. 2005;79:461-465.[CrossRef][Medline] [Order article via Infotrieve]
  • Food and Drug Administration. Zinecard (dexrazoxane for injection). NDA 20-212/S-008. Available at: http://www.fda.gov/medwatch/safety/2005/MAY_PI/Zinecard_PI.pdf.
  • Food and Drug Administration, Center for Drug Evaluation and Research. FDA oncology tools approval summary for dexrazoxane for reducing the incidence and severity of cardiomyopathy, October 31, 2002. Available at:http://www.accessdata.fda.gov/scripts/cder/onctools/summary.cfm?ID=256.
  • Hensley ML, Schuchter, LM, Lindley, C, et al. American Society of Clinical Oncology clinical practice guidelines for the use of chemotherapy and radiotherapy protectants. J Clin Oncol. 1999;17:3333-3355.[Abstract/Free Full Text]
  • Marzatico F, Porta C, Moroni M, et al. In vitro antioxidant properties of amifostine (WR-2721, Ethyol). Cancer Chemother Pharmacol. 2000;45:172-176.[CrossRef][Medline] [Order article via Infotrieve]
  • Kemp G, Rose P, Lurain J, et al. Amifostine pretreatment for protection against cyclophosphamide-induced and cisplatin-induced toxicities: results of a randomized control trial in patients with advanced ovarian cancer. JClinOncol. 1996;14:2101-2112.[Abstract/Free Full Text]
  • Food and Drug Administration, Oncology Division Advisory Committee. Fulfillment of the accelerated approval requirements for the non-small cell lung cancer indication: ethyol (Amifostine) reduces the cumulative renal toxicity associated with repeated administration of cisplatin in patients with advanced non-small cell lung cancer. Available at:http://www.fda.gov/ohrms/dockets/ac/03/briefing/3936B1_05_MedImmune-Eythol.htm.
  • Schiller JH. High-dose cisplatin and vinblastine plus amifostine for metastatic non-small cell lung cancer. Semin Oncol. 1996;23:78-82.[Medline] [Order article via Infotrieve]
  • Brizel DM, Wasserman TH, Henke M, et al. Phase III randomized trial of amifostine as a radioprotector in head and neck cancer. J Clin Oncol. 2000;18:3339-3345.[Abstract/Free Full Text]
  • Lipshultz SE, Rifai N, Dalton VM, et al. The effect of dexrazoxane on myocardial injury in doxorubicin-treated children with acute lymphoblastic leukemia. N Engl J Med. 2004;351:145-153.[Abstract/Free Full Text]
  • Omenn GS, Goodman GE, Thornquist MD, et al. Risk factors for lung cancer and for intervention effects in CARET, the Beta-Carotene and Retinol Efficacy Trial. J Natl Cancer Inst. 1996;88:1550-1559.[CrossRef][Medline] [Order article via Infotrieve]
  • Food and Drug Administration. Gefitinib (marketed as Iressa) information. 2005. Available at:http://www.fda.gov/cder/drug/infopage/gefitinib/default.htm.
  • Mosman Communications, Inc. Industry news: AstraZeneca posts US$21B sales. Medical Observer. May 15, 2005. Available at:http://www.medobserver.com/mar2005/indnews.html.
  • Lissoni P, Barni S, Brivio F, Rossini F, Fumagalli L, Tancini G. Treatment of cancer-related thrombocytopenia by low-dose subcutaneous interleukin-2 plus the pineal hormone melatonin: a biological phase II study. J Biol Regul Homeost Agents. 1995;9:52-54.[Medline] [Order article via Infotrieve]

Tags: , , , ,

Nutrition Plays a Critical Role in Cancer

Chris Woollams presents an argument against chemotherapy. The reply, by the medical profession, can be found here.

Hospital Pass

Open quotesAll the patients in the ward are dying of cancerClose quotes

I’m sitting in a room in a Hospice. My daughter is asleep with her brain tumour. But in the last few days I have had several interesting conversations.

All the patients in the ward are dying of cancer. In Catherine’s case her oncologist has said that there is nothing more he can do and so he has passed her on to palliative care and the Hospice. I suppose I should accept that, at this stage, all bets are off, but it’s not in my nature to sit back idly and no longer try. I even turned the radio on yesterday and the first words I heard were ‘never give up, never give up’ in a pop song. Spooky.

But Catherine drinks her Ribena, has a breakfast of Rice Crispies or Bran Flakes with milk and eats the excellent fish in cream sauce, and ice cream, all provided by the NHS.

Junk food

A sense of ‘deja vu’ passes over me. Earlier in the year two readers sent in a booklet from The Royal Marsden which provided information on what patients should eat whilst having chemotherapy. So alarmed were we by the recommendations featuring cancer-fuelling high levels of fat, sugar and salt – the booklet even showed pictures of milk shakes, cheeseburgers and doughnuts – we asked ten different cancer centres to give us their views. In the Royal Marsden’s defence we discovered that their dieticians were so overworked they only had time for about 7-10 per cent of all patients; always those who were losing weight fast and thus their diet recommendations were specifically designed to tackle these extreme cases. However, the booklet still went out toall chemo patients.

But I do wonder, and worry. When Catherine ‘came-to’ after a brain tumour operation in February, her hospital diet again was dairy and sugar-based.

Let’s get it straight. As any half decent biochemist will tell you

  • Glucose is the favourite food of a cancer cell. Ribena has four times the sugar of coca cola. Glucose fuels cancer and we’ve known this since 1931. Worse, new research has shown that within 15 minutes of eating sugar certain areas of the immune system can be depleted by up to 90 per cent!
  • Dairy contains IGF1 and this has been known to help propagate cancers since 1992.
  • Salt (sodium) helps imbalance your cellular power stations by displacing potassium. It powers them down and encourages a state favoured by cancer cells.

Why don’t hospital cooks know this?

Myth and Reality

Open quotesGlucose fuels cancer and we’ve known this since 1931Close quotes

Certainly the nurses did not know, but they were very keen to learn. All unanimously praised icon for its information and its breadth – they like the fact that it covers diet and chemotherapy, supplements and radiotherapy equally and open-mindedly.

As the discussions developed, we got on to subjects like B-17. As readers know, I am neither ‘for’ B-17 nor ‘against’ it. I am completely open-minded and I believe it is time to research it properly in a fair and unbiased way. We all need to know the truth. The standard criticism of B-17 is that ‘it contains cyanide’. But then so does vitamin B-12 and no one in their right mind is suggesting we ban vitamin B-12 in the UK. It is essential to over 300 biochemical pathways. In some quarters, ‘experts’ claim that there is no evidence that B-17 works to kill cancer cells. But, in fact there are 5 studies – on animals and humans – saying it does.

Some ‘experts’ say that this cyanide content of B-17 means it is dangerous and could kill people. So where is the factual evidence of B-17, when properly administered by qualified doctors, showing the side effects of killing people? What percentage does it kill? Again we’d simply like to pass this on to our readers.

Open quotesWe all need to know the truthClose quotes

The same scenario goes for The Gerson TherapyMistletoe,Hydrazine Sulphate etc. etc. etc. (Mistletoe has thorough clinical trials in Germany, Hydrazine Sulphate in Russia yet these seem generally ignored in the USA and UK).

So increasingly in the UK – in the absence of any full and proper data on such alternative or complementary therapies – we are herded down a tunnel labelled “Surgery,Radiotherapy and Chemotherapy“.

And here’s the rub. Catherine’s five nurses had a number of views on chemotherapy. Broadly they were in three areas.

  • There are a number of new drugs which are supposed to be wonderful (they couldn’t name any)
  • The drugs they use now have some terrible side effects
  • Doctors don’t really know about this because they don’t come often enough to the coalface!

Side Effects

Cod live oil

Recently there have been a number of press reports about the use ofComplementary Alternative Medicines, such as fish oils and herbs and how people taking these must be careful because of their side effects, especially where they might interact with prescribed drugs. Some people are even proposing restrictions, prescriptions and warning labels.

But when the nurse gives Catherine her eleven pills with her breakfast, are any similar warnings given to Catherine on side effects? What is known about the interaction of the four or five different types of drug? Have there been trials conducted on this concoction? Of course not; just on the individual elements.

As an ex-advertising man you would expect me to want drugs to be advertised on TV. But, in fact, a US TV ad for a drug makes the side effect point better than I can ever do. The first 10-12 seconds of the ad tells you what the drug can do for you; the next 15-18 seconds lists the side effects. It’s the law.

Every drug you put in your mouth has a side effect. Fact. And most usually the doctor will try to control that side effect with another drug. That is why some patients take three or four types of drug and why there is no such thing as a poor pharmaceutical company.

Open quotesEvery drug you put in your mouth has a side effectClose quotes

Three and a half years ago, my daughter was ‘given’ six months to live by her oncologist. She had a grade 4 tumour then and he told me a life expectancy of six months was his considered view. The maximum anyone had survived was 18 months. As readers may know, after 12 months her scans kept showing “all clears” and two doctors encouraged me to write the book, Everything you need to know to help you beat cancer.

I was approached for information by someone about her cousin, who also had a brain tumour. By coincidence he was under the same oncologist as Catherine. However he, being rich and ex-city, had sought a second opinion in Dukes Cancer Center in the USA. They told him that the drug doses provided in the UK were too low and he should virtually double them. So he did.

Interestingly in my conversations with him, he told me that every time he went on holiday to the sun (South Africa, Barbados) his tumour stopped growing. Was that rest, relaxation, the effects ofVitamin D? Did anybody look into why this might be so? No.

Open quotesEvery time he went on holiday to the sun his tumour stopped
growingClose quotes

I saw him last at the National Brain Tumour Conference, where I was giving a speech. He was ashen-faced with scabs on his lips. Clearly the chemotherapy was taking a toll on his immune system. However, he said he felt fine and was very positive. He left the conference on the Tuesday, went to watch a golf match with his father on the Thursday, collapsed, and died on the Saturday. His death is recorded as cancer and a brain tumour. He actually died because the drugs caused a haemorrhage in a blood vessel in his brain.

The Urban Myth

Now back in July when some of the medical profession were seeking to rubbish Prince Charles for his comments on The Gerson Therapy, Professor Michael Baum made a number of points (see iconSeptember/October 2004) -

  • That there will always be people who live longer than expected; he called this the Urban Myth.
  • That unless Complementary Therapies (such as Gerson) subjected themselves to the same rigorous standards as drugs have to pass, they would be forever condemned to the peripheries of medicine.

Professor Baum, unfortunately in my opinion, makes it all sound like a special club with clear rules for membership.

Let me make it clear. I am completely behind proper, definitive research, on which to base judgements. My problems are threefold -

  1. That there have been incidences of ‘clinical trials’ on drugs being less than vigorous, side effects hidden, judgements on their conclusions treated over-enthusiastically, but that ‘once approved (for example by the FDA in America), these drugs are accepted, full stop’.
  2. That too often research on complementary and alternative therapies is non-existent, or trivial, or conflicting, (for example – see Cancer Watch on gastro intestinal cancers this month), and this makes it easily criticised.
  3. That the majority of the medical profession thus places its trust in the former and simply dismisses the latter resulting in this vision of drugs as our salvation.
Open quotesSo where has this obedience to chemotherapy and the clinical trial taken us to date?Close quotes

So where has this obedience to chemotherapy and the clinical trial taken us to date?

Complacency Rules

Let me quote you some figures.

1) The National Audit Office has stated in 2004 that over the last 30 years, 5-year survival rates for cancer patients have improved by 12 per cent. What? Only 12 per cent, despite all the money being spent on drugs and treatments?

Certain cancers, for example child leukaemias and testicular, are very treatable by chemotherapy agents. Skin cancers, which have roared into the ‘charts’ in the UK in second place are also very treatable. Where does that leave the rest of the cancers?

Well I’m glad I asked.

2) Accordingly to the National Audit Office, 5-year survival rates vary greatly by cancer type, but we are now in line with Europe. Not true.

Take Breast Cancer, for example:

Checking the breast

In Eurocare-3, the best country was Sweden with about 83 per cent survival, then France and Germany with over 81. Where was the UK? Answer; Around 73 per cent. Below the average for Europe; but reassuringly above the likes of Poland and Latvia.

Try Prostate Cancer; if you dare. Top, Austria at 83 per cent. The UK?Below the average for Europe, at 53 per cent.

In fact, if you want to feel discouraged let’s look at the overall figures:

All men’s cancers (%)

  • Europe Average (40.5)
  • England (37.1)

All women’s cancers (%)

  • Europe Average (53.6)
  • England (50.8)

This is the URBAN MYTH, Professor Baum. That radiotherapy and chemotherapy ‘CURE’ cancer. They don’t.

Open quotesStill we seem destined to merely ape the USAClose quotes

But still we seem destined to merely ape the USA, with more “wonder drugs” and “breakthroughs” almost a weekly occurrence.

Yet the US has 5-year survival rates of only 51 per cent for whites and 48 per cent for blacks.

And the prestigious MD Anderson Cancer Center in Texas is stating quite clearly that, ‘all the exciting developments in cancer are coming in areas other than chemotherapy.’

The Austrians use a number of herbal remedies. In Germany top oncologists are often trainedhomeopaths. They may test their patients with Vega machines to look for allergies, toxins and the like. Which doctors in the UK have even seen a Vega machine? In Germany, if the first treatment doesn’t work, the oncologist has to give you an alternative by law. My local GP in France is also a qualified homeopath and claims he has never given anyone an antibiotic. And France has the best healthcare service in the world according to the WHO (World Health Organisation). When will we open our eyes?

Chemotherapy

The fact is that historically chemotherapy drugs were like dropping a nuclear bomb on Watford because there was a known terrorist cell there. Even then this was no guarantee that one would not have gone to London for the day.

Open quotesPlease don’t get me wrong – I am not anti-chemotherapyClose quotes

Please don’t get me wrong. I am not anti-chemotherapy. If I had testicular cancer, or child leukaemia I would probably have the drugs. If I had pancreatic cancer or a brain tumour I certainly would not. I am simply ‘anti’ the blind faith of the medical profession; the back slapping, pseudo-euphoria that meets a new drug launch; that espouses that somehow drugs cure cancer.

Now there is no doubt that scientists are trying to develop the smart bomb for cancer: The missile that goes down streets, round corners and only hits the house with the terrorists in it. And I’m very happy about this.

Unfortunately while we wait, more innocent victims are suffering, because the majority of the drugs do not actually deliver a ‘cure’, but do deliver a host of debilitating side-effects.

Trials and Tribulations

Hardly a day passes without more claims for yet another wonder drug. The pharmaceutical companies have excellent PR machines, aided and abetted by a few over-enthusiastic scientists and doctors.

Take Professor Alex Markham, chief executive of Cancer Research UK. In an interview in The Times on 20th September 2004 he was positively ecstatic. “It is an extraordinary fact. In 2004 we will put almost 30,000 patients into (drug) trials, while the US does about 25,000. We have never done so well. Survival rates for adult cancers have increased by 1 per cent a year over the last decade (Note: this disagrees with the National Audit figure of 12 per cent in 30 years). We cure 43 per cent of people who develop cancer in this country.”

Open quotesWe cure 43 per cent of people who develop cancer in this countryClose quotes

Oh, heaven and euphoria.

He is worried about three cancers: lungpancreas and oesophagealbut does not mention the rising tide of brain tumours or oestrogen-driven cancers. In the young (where child leukaemia does have effective drugs) he claims we have “gone from 70 per cent dying to 70 per cent surviving”.

“Cure”. “Surviving”. The words just roll off his tongue without hint of their true meaning or the asterisk in the research report that says “for 5 years”. Indeed in children, brain tumours are clearly growing behind leukaemia with no “cure” in sight and little research being done.

Now, it is true that some drugs are accepted as merely life-extenders, for 4 months or 4 years, and no one can dismiss this benefit providing it is not gained at too great a cost.

A further cautionary note was sounded at the European Breast Cancer Conference in 2004 by several scientists who warned that drugs were being rushed onto the market before trials were even finished, whilst “success” claims were being made even earlier.

In breast cancer the “gold standard” is Tamoxifen. It acts to block oestrogen receptor sites. It is known to have serious side effects, so much so that the World Health Organisation has dubbed it a class A carcinogen itself! In California where a fair amount of Tamoxifen is made, what did they do about this? Well, of course they tried to have the WHO banned!

Open quotesThe very original trial and application for Tamoxifen was turned down by the FDA because of the side effectsClose quotes

If you read the work of Phillip Day and Steve Ransom you will be told that the very original trial and application for Tamoxifen was turned down by the FDA because of the side effects. A while later the same trial was re-presented, and again turned down. Undeterred, and knowing the FDA needed something (anything?) that might help in the fight with breast cancer, the same original trial was re-presented a third time, and gained approval. Is this what Professor Baum regards as the rigorous system to which the likes of Gerson should aspire, one wonders?

Tamoxifen is largely given to women after breast cancer has appeared and to prevent a reoccurrence. However, it is also used as a preventative drug in cases where women are at high risk. As you will see in this issue’s Cancer Watch, new research says that its benefits in these cases are doubtful, whilst its side effects are definitely dangerous. Where were the rigorous clinical trials on Tamoxifen as a preventative agent, for women as yet untouched by cancer? None exists.

In September 2004, the Daily Mail carried a story about Femara (Letrozole), an oestrogen inhibitor, which has just been approved by UK authorities. “Doctors have hailed the drug as a landmark in the treatment of the disease. Until now the “gold standard” has been Tamoxifen. But it can be taken for only five years, after which it becomes less effective and has serious side effects, ” says the article.

The article continues by saying that a third of women with breast cancer have a relapse and more than half of them occur after Tamoxifen has ceased.

Again excuse me for arguing fact here but in 2001 Government figures show that there were 39,000 or so cases of breast cancer and ‘mortality’ was approximately 13,500, which is a bit more than a ‘relapse’.

And whilst I don’t doubt for a minute that these oestrogen-reducing drugs are a major new force in treating breast cancer, I wonder if this indicates just how confused the medical profession as a whole is becoming.

Open quotesWell which one is it? Too little oestrogen, or too much?Close quotes

Hasn’t the same profession been telling women for ten or more years that on reaching menopause it would be a good idea to take more oestrogen because they didn’t have enough. Hasn’t this view spawned enormous income for the pharmaceutical companies in HRT.

Well which one is it? Too little oestrogen, or too much? Either way the pharmaceutical industry has it covered.

(Interestingly the same newspaper, same edition, carried a report from the USA saying that Prozac, and other similar antidepressants like Seroxat, Effexor and Cipramil, all approved in previous trials were now thought to increase the chances of suicide in teenagers! This, of course, raises another point which is how long is enough for a drug trial?)

All I want is honesty. More honesty and less ’spin’ and ‘hype’ It’s not too much to ask, is it? The US solicitor Spitzer has threatened Glaxo with a class action because it extolled the virtues of one of its drugs, without saying too much about the numerous negative side effects found during the trials.

The FDA are so hard pressed monitoring all the trials of all the new drugs they needed more staff. What happened? The nice pharmaceutical companies loaned them some of theirs. The phrase ‘poachers turned gamekeepers’ springs to mind.


In Science Notebook, in The Times in September 2004, Anjana Ahuja wrote:

Honesty is the best medicine if you’re a drugs giant with something to hide

In an interview for T2 last week, Richard Horton, editor of The Lancet, was startlingly candid about how pharmaceutical companies sway research agendas, buy up academics and peddle overpriced, improperly tested drugs. Researchers who take the corporate shilling, he told me, make a “bargain with the Devil”.

Now read this from The New York Review of Books and written by Marcia Angell, the former editor of the New England Journal of Medicine. The pharmaceutical industry is “primarily a marketing machine to sell drugs of dubious benefit… [and] uses its wealth and power to co-opt every institution that might stand in its way, including the US Congress, the Food and Drugs Administration, academic medical centres, and the medical profession itself”. Angell expands her tirade in a new book, The Truth about Drug Companies: How They Deceive Us and What We Can Do About It.

Their attacks could hardly have been timed better. A fortnight ago 11 medical journals announced that they would refuse to publish the results of clinical trials unless those trials had been registered at their inception. The idea is to prevent companies publishing only flattering results. Since published trials are often pooled in umbrella studies – meta-analyses – the absence of disappointing results, while keeping share prices buoyant, can misrepresent the usefulness and even safety of medicines. Dr Richard Sullivan, from Cancer Research UK, says it is possible that some patients are receiving ineffective drugs because consultants are unaware of negative findings buried in unpublished data. Given that some anti-cancer therapies have unforgiving side-effects, it is a serious matter.

The Pharmaceutical Research and Manufacturers of America, to which giants such as Merck belong, said last week that it would create a database to which companies could voluntarily contribute both good and bad trial results. But the idea met a brutal response. Catherine de Angelis, the editor of the Journal of the American Medical Association, asks: “Why would you put the fox in charge of the hen house?”

Critics have it in for the Big Pharma, and they are certainly not bothering to sugar the pill.


Catherine Woollams

When Catherine was first ill and having radiotherapy she asked her doctors what would they recommend if the treatment failed. They said that they’d been at a US conference and they had a new drug in the US called Gleevec which he wanted to bring in the UK and, they added excitedly, that they could use it for Catherine.

I interjected that Gleevec was made by a Swiss company Novartis. It had been used in trials with 89 glioma patients (in fact, it was called Glivac, previously). It did not work at all. However, in other trials with another cancer (myeloid leukaemia) it had been found to have real merit, it had received FDA approval for that cancer and changed it’s name to Gleevec. Why would you want to give it to my daughter for her glioma?

Worse was to follow. My ex-wife and daughter went to see the doctors when the tumour re-appeared. Who said they planned to use a combination of three drugs, called PCV, and this had ‘a 70 per cent success rate’. This is TOSH. 70 per cent ‘cure’? 70 per cent survive 5 years? What? PCV actually made Catherine so ill she could only take one round. She had no white cells left at all.

Open quotesPCV actually made Catherine so ill she could only take one roundClose quotes

But the medical profession can give you injections to get your white cells back up. Imagine seeing your daughter injecting herself so much she couldn’t walk as a result. And the white cells did not return.

At the Brain Tumour Conference, Angela and Neil Dickson of SDRT told me that they had just been to a conference where scientists said PCV should be banned because it so debilitated the immune system, and it had only ever shown a little success in children under 5.

The doctors next recommended Temozolamide (which anyway only has FDA approval for Grade 3 tumours). This had undergone trials amongst 54 people for just one year, with 5 having their tumour disappear during that time. Is this the sort of standards of excellence required to join Professor Baum’s special club?

This drug didn’t work either, and Catherine’s immune system stayed low and, again, she could not have a second round of the drug.

But then, I truly feel sorry for oncologists. The medical system pushes them towards surgery, radiotherapy and chemotherapy, and for brain tumours, the chemotherapy doesn’t work. You don’t have to believe me. The Lancet in February 2004 says it doesn’t work for brain tumours, just as Professor Pilkington said in icon in May 2003.

Open quotesI truly feel sorry for oncologistsClose quotes

Meanwhile in MD Anderson, they are testing a new type of drug which stops the growth factors of brain cancer cells. It’s called Tarceva. One little problem. Just a little too often it causes a brain haemorrhage!

Chicken and Egg

What are we trying to do? I know that drugs are being developed which will be more targeted and not kill so many good cells. We now understand, much more clearly, the biochemistry of the cancer cell and how it differs from the normal cell and so we can make smart bombs that are far less cytotoxic. I know that others are being developed that, for example like Arimidex, cut the cancer cells’ fuel, or target a unique enzyme or property of the cancer cell. I am all for this.

But.

We seem hell bent on ignoring one, not so little, factor.

Open quotesPeople with weaker immune systems develop more cancersClose quotes

Research in the USA last year came up with the conclusion we all would have expected: People with weaker immune systems develop more cancers. A weak immune system gives you less of the defenders you need to deal with any attacking cancer cell. And remember each of us develops at least 200 or so pre-cancerous cells per day; our immune systems have developed during our evolution to deal effectively with them all.

We have various levels of immune system. To keep it simple I’ll divide it into three parts.

  • friendly bacteria in the gut: These aid digestion, produce biotin (an essential antioxidant) and crucially devour yeasts, microbes and fungi that you ingest daily. Without them your first line of defence is missing.
  • your liver: The largest organ in your body and responsible for cleaning and detoxifying your blood. Without a fully working liver toxins start to pile up around the body causing the whole immune system to ‘clog up’.
  • your white cells: These have a variety of separate but interrelated functions; for example to identify foreign invading cells, to neutralise them and to help remove them from the system.

Let’s take these in turn:

It is quite simply a fact that to take steroids, antibiotics or chemotherapy destroys the friendly bacteria in the gut.

Open quotesTo take steroids, antibiotics or chemotherapy destroys the friendly bacteria in the gutClose quotes

This allows the harmful yeasts, bacteria and microbes to multiply. In the presence of their favourite foods (like sugar, alcohol, refined carbohydrates, dairy and yeasty foods) they will multiply and even enter the blood system. They can colonise in areas of the body and they are anaerobes (don’t need oxygen), just like cancer cells. Some experts go as far as to link their presence to cancer.

The effects of chemotherapy greatly weaken the liver’s detoxification abilities. For example, chemotherapy and radiotherapy kill cells. Some cancer cells, some normal cells. And the dead cells pass to the liver, which has to work hard to break them down and pass them out into the intestines. Cholesterol builds up around some of the dead cells to form stones, sometimes several thousands of them. These in turn block the bile ducts and prevent the elimination of toxins. One US estimate was that virtually every cancer patient had these gallstones. The effects of chemotherapy greatly weaken the liver’s detoxification abilities.

And so the whole immune system ‘backs up’ and it becomes harder to get the toxins out of the body.

But finally, most of these drugs destroy your white cells leaving you with little or none of nature’s defence against foreign cells – like cancer cells.

And that’s the conundrum. At the very moment you need your immune system in tip top working order, most chemotherapy flattens it. Temporarily or even permanently.

Charlotte Gerson

Talk to Charlotte Gerson and she will amplify this further. With brain tumours she claims a success rate of about one third of people coming to her clinic. But if patients have already had chemotherapy, this falls to just 2 or 3 per cent, she says.

Some cancer experts will tell you that patients already have a weakened immune system caused by the cancer. Chicken and egg. But Catherine’s measured blood ’scores’ fell through the floor when she had chemotherapy, and the injections couldn’t return them at all. Indeed it was only a course of Cat’s Claw, Astragalus and organic iron that took her back to somewhere near normal.

Of course some cancers can ‘hide’ from the immune system. But then there are scientists working on ways of ‘kick starting’ the immune system. In icon we already covered one such treatment: Dendritic Cell Therapy.

The $64,000 Question

So, how many doctors and oncologists say to their patients at the moment of diagnosis “Right Mr Jones; the first thing we must do is get your immune system in tip top working order to help it recognise the rogue cells. After all, we want your body in its best fighting shape.”

In Michael Gearin-Tosh’s book (Living Proof: A Medical Mutiny), Dr Wheatley (a doctor of philosophy) quotes Dr Jeffrey Bland, a biochemist who simply states that every cancer therapy should include nutritional consultation as a standard of care. Not to, he says, should be considered, “malpractice by omission”.

Open quotesThe WHO estimate that 50% of all cancers are caused by poor diet; 25% by toxins and 25% by infectionClose quotes

I will tell you now that everyone we talk to, who has just been diagnosed with cancer, is nutritionally toxic (for example, too much salt in their diet) and/or nutritionally deficient (they simply don’t ingest decent levels of antioxidants through diet and/or supplements).

The World Health Organisation is quite clear. They estimate that 50 per cent of all cancers are caused by poor diet; 25 per cent by toxins and 25 per cent by infection.

Do doctors start at this point? Could there be an infection? We have recently completed our own independent blood tests on Catherine and they show that she definitely has a fungal infection in her brain and there is a trace of viral infection. Might not these just possibly be causal?

Of course, the patient may need surgery and it is possible that radiotherapy will help – although US research suggests it only has a 15 per cent 5-year “cure” rate.

And yes, some cancers respond to chemotherapy. But the point is that only a very few can be curedcompletely by chemotherapy, most merely, to some degree, are just managed by chemotherapy. So please will people – supposedly sensible people at that – stop OVERCLAIMING!

Poor Defence

The fact is that if a doctor quickly opts for chemotherapy he is saying that he expects the drug – not your flattened natural defences – to do all the work. And this is simply not credible. Not all the cancer cells may divide during the period of the chemotherapy. Some may even develop their own immunity, and it only needs one to survive.

Open quotesNot all the cancer cells may divide during the period of the chemotherapyClose quotes

Recently I saw some pictures taken using laser light and Russian algae. The chlorophyll in the algae binds to the cancer and pre-cancer cells. The patient had a breast tumour. Before chemotherapy she had three “hot spots” in her breast and a few elsewhere in her body. After chemotherapy the main “hot spots” were smaller but there were a dozen or so around her body.

And there is the rub. Cancer is systemic. The symptoms exist throughout your whole body, they may only manifest themselves in a tumour in one location. This is why it is so hard for radiotherapy or surgery to have long-term effect.

With Catherine recently we discussed what she was doing now versus what she did in year one when cancer was under control. In fact she is more diet conscious now. She doesn’t smoke, take the pill or drink alcohol.

The difference between now and then? A much, much poorer immune system, destroyed by several different chemotherapy drugs the Lancet says don’t work anyway.

Are we angry? No, sad. And completely mystified. Doctors have taken an oath to try to heal people. And to do nothing to harm them. But we feel that doctors don’t even consider the basics.

Open quotesWe feel that doctors don’t even consider the basicsClose quotes

For example:

  • your diet
  • your immune system
  • your chances of yeast or other infection
  • your body energy

Worse, some doctors even laugh, snigger, disparage and discourage patients who dare to suggest taking independent action in these areas.

Actually they’ve probably never even studied them, so it’s not their fault. It’s the fault of the system that trains them and the system that uses all our top doctors, scientists and professors to endlessly test drugs.

Professor Julian Peto of Oxford University and Cancer Research UK was quite clear about this in his speech at the National Conference of Self Help and Support Groups 2003. He stated that there was too much drug research and it took our top doctors and scientists away from investigating possible causes of cancers and bright alternative ideas for their treatment. Certainly if I want to know about cancer causes or complementary therapies the answers rarely lie in the UK or the USA. Most usually the work is taking place in Sweden or Singapore or Australia, Russia or Japan. And what happens when Cancer Research report these findings? Well their PR releases tend to say that the conclusions are “very interesting but more research will have to be done before any action can be taken”. And presumably this means the type of research that gains entry to Professor Baum’s club.

And then they never do it; in the UK we simply do not find the funding for non-drug research.

Open quotesIn the UK we simply do not find the funding for non-drug researchClose quotes

Ask Professor Pilkington whose team has found merit in six natural substances with brain tumours. The project has been scrapped; cancelled for the third time through lack of funding.

We must conduct research on a wide spectrum of possible cancer treatments. Yes, even the Gerson Therapy. Proper research that has one group of people on drugs and an identical group on diet therapy. You see I want to see vigorous research on complementary and alternative therapies too. More research, more honesty, less ’spin’ and less ‘hype’, less uninformed criticism. But the harsh reality is that funding is simply not there. In New York, as we covered in icon in September, Doctor Gonzalez is about to embarrass the FDA. In his diet therapy trial, all but one of his patients has lived the full five years, and considerably longer than those who took the chemotherapy! This is funded by a special US Government body specifically set up to do this sort of research.

You see I actually agree with Professor Baum when he says these other treatments need to be researched or else they will remain on the periphery. But that is not to say that they do not have credibility at the moment. Ask the patients who use them!

Physician Heal Thyself

Open quotesAs I said before, I don’t blame doctorsClose quotes

As I said before, I don’t blame doctors. They work within a system and to recommend vitamin supplements for example over a “tried and trusted” drug might see them struck off.

But this is not to say they couldn’t suggest using vitamin supplements or diet as well. If I ran a cancer clinic I would simply want to do my level best to cure that poor patient sitting in front of me. And I would read and read, study and study and I would want to try different approaches if I didn’t feel the official ones were successful enough.

And let’s face it, with five-year survival rates of 9 per cent on pancreatic cancer, 15 per cent on brain tumours, and even 53 per cent on prostate cancer, I don’t think anyone in UK medicine is in any position to factually disprove me when I say that in my opinion chemotherapy has helped kill my

Tags: , , ,

Fantastic Book – Chemotherapy Heals Cancer And The World Is Flat

Chemotherapy Heals Cancer and the World is Flat

See larger image
Tell the Publisher!
I’d like to read this book on Kindle

Don’t have a Kindle? Get yours here.

Chemotherapy Heals Cancer and the World is Flat (Hardcover)

by Lothar Hirneise (Author)


List Price: $49.90

Editorial Reviews

Product Description

In the future there will be two groups of cancer patients. Those who have read this book – and those who are uninformed. For many years Lothar Hirneise has been traveling throughout the world looking for the most successful cancer therapies, and he has been explaining to people that there is much more available than just chemotherapy and irradiation. Recognized internationally as Europe’s leading specialist in this area, he describes the results of his years of research in this encyclopedia of non-conventional therapies. The reader will also learn in detail why so-called experts in reality know little about cancer. In addition to descriptions of more than 100 cancer therapies and substances used in treating cancer, the author also explains which cancer therapies are used allopathically, for which types of cancer, and what is imperative for a patient to know before he subjects himself to such therapies. The 3E program, which is based on the analysis of case histories of thousands of people who have survived late stage cancer, is also described for the first time. Learn why so many people die of cancer, and why so many others do not. This book not only supplies an incredible amount of information, it also helps the cancer patient to find his own way to cure cancer through the active exercises of the 3E program.

About the Author

president of People against Cancer Germany (www.krebstherapien.de), director of the German holistic Cancer Information- and Consulting Center (www.dgk-buoch.de) and author of the bestseller: Chemotherapy heals cancer and the world is flat (www.nexus-book.com).


Product Details

  • Hardcover: 774 pages
  • Publisher: Nexus Gmbh (October 1, 2008)
  • Language: English
  • ISBN-10: 3981050207
  • ISBN-13: 978-3981050202
  • Product Dimensions: 9.2 x 6.6 x 2 inches

In an age of such great advancements as walking on the moon and sending landers to Mars we are such barbarians when it comes to neoplastic conditions. In Lothar Hirneise’s book “Chemotherapy Heals Cancer and the World is Flat”, we are presented with a level headed and scientific view of Alopathic medicine and its counterpart Alternative medicine. We are educated on the fact that the alternative existed for hundreds of years without employing poison to cure and given abundant examples of existing treatments that are both available and affordable.

I was impressed by the authors detailed accounts when discussing first hand encounters with researchers from around the world that are finding ways to combat this terrorist. Cancer is best fought with a variety of tools to accomplish the goal of setting your internal terrain back in a correct state.

This book is worth its weight in Gold and for those considering the very best way to fight cancer without compromising your immune system I can think of no better resource save a direct encounter with one of the many cancer warriors mentioned in the book.

A few other great resources to consider:

Dr. Ralph Moss of cancerdecisions.com
Dr. Dan Rogers of gersonplus.com
Dr. Soren Nielson of cancer-smart.net
Tony Isaacs Oleander Soup – tbyil.com
and naturalchemotherapy.com/blog

Tags: , ,